NMD Pharma company information, funding & investors | Dealroom.co
NMD Pharma company information, funding & investors | Dealroom.co
Management — NMD Pharma
NMD Pharma
Management — NMD Pharma
Company Presentation
NMD Pharma company information, funding & investors | Dealroom.co
NMD Pharma
Management — NMD Pharma
NMD Pharma is Strengthening Muscles in Neuromuscular Disorders
NMD Pharma company information, funding & investors | Dealroom.co
Nmd Pharma A/S, Aarhus N | firma | krak.dk
NMD Pharma
NMD Pharma is Strengthening Muscles in Neuromuscular Disorders
NMD Pharma to advance neuromuscular disorder therapies with €38m Series A round
Big deal: NMD flexes series A muscles - Global University Venturing
Company Presentation
Tunge pengetanke klar til nye investeringer i biotekselskab fra Aarhus
NMD Pharma Initiates a Combined Phase I/IIa Clinical Trial of NMD670 for the Treatment of Symptoms of Myasthenia Gravis
Contact — NMD Pharma
NMD Pharma raises €38M (~USD 47 Million) SERIES A Financing to Advance Treatments of Neuromuscular Disorders
NMD Pharma
NMD bags €38M to run orphan neuromuscular disease trials | FierceBiotech
Investors — NMD Pharma
